🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To study signals of efficacy and safety of a currently available dosage for...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-03-04
Trial ID
NCT04561180
Treatments Being Tested
The primary objective of this trial is to compare the preference between tw...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-07
Trial ID
NCT02410590
Treatments Being Tested
The purpose of this study is to compare the risks of COVID-19 in individual...
Status
Completed
Location
University of Chicago
Start Date
2020-12-28
Trial ID
NCT07128069
Treatments Being Tested
This is a double-blind, randomized, placebo- and active-controlled study in...
Status
Recruiting
Location
Nucleus Network
Start Date
2025-10-06
Trial ID
NCT07207954
Treatments Being Tested
Multicenter, randomized, parallel-group, double-blind, double-dummy, compar...
Status
Completed
Location
Eurofarma Laboratorios S.A
Start Date
2024-07-08
Trial ID
NCT05214911
Treatments Being Tested
The purpose of this study is to find out whether IMPRINT in combination wit...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited protocol activities)
Start Date
2021-08-10
Trial ID
NCT04897022
Treatments Being Tested
This randomized phase III trial is studying APF530 and dexamethasone to see...
Status
Completed
Location
Anniston Oncology, PC
Start Date
2006-06
Trial ID
NCT00343460
Treatments Being Tested
The primary objective of this study is to compare the QVAR-Easi-Breathe 100...
Status
Completed
Location
Allergy and Asthma Specialists
Start Date
2004-10-31
Trial ID
NCT00094016
Treatments Being Tested
ITP patients with low platelet count and active bleeding symptoms are at ri...
Status
Recruiting
Location
Henri Mondor Hospital
Start Date
2022-04-07
Trial ID
NCT04968899
Treatments Being Tested
This is a Phase II/III, randomized, double-blind, placebo-controlled, multi...
Status
Completed
Location
Univ of Alabama School of Med; Clinical Immun Rheumatology
Start Date
2005-05-10
Trial ID
NCT00137969
Treatments Being Tested